A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies

Patients with hematological malignancies have an increased risk of serious outcomes following COVID-19 infection, suggesting broader protection is needed beyond vaccination. Monoclonal antibodies such as sotrovimab, casirivimab–imdevimab, and bamlanivimab have provided valuable options for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Carolyn, Robinson, Sue, Christofides, Anna, Sehn, Laurie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222187/
https://www.ncbi.nlm.nih.gov/pubmed/35735424
http://dx.doi.org/10.3390/curroncol29060315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222187/
https://www.ncbi.nlm.nih.gov/pubmed/35735424
http://dx.doi.org/10.3390/curroncol29060315

Ejemplares similares